The peptide research and studies library

Four shelves, with the limits left visible

The literature includes cell work, animal models, small human studies and research on defined medicines. They answer different questions. A paper’s abstract and methods determine where a result belongs.

This is a curated reading list, not a complete count of the field. Claims about tens of thousands of indexed papers or a fixed number of citations are not used as evidence of quality.

A cream archive folio opens onto layered teal rails, mustard discs and lilac paper slips — The reading trail is more useful when every conclusion stays attached to its study.

Tissue repair and regeneration

Reading theme	What the earlier library explored	Question to carry into the paper
Reading theme: BPC-157 reviews	What the earlier library explored: Vascular signalling, nitric oxide and repair across models	Question to carry into the paper: Is this a review, a primary experiment or a human outcome study?
Reading theme: Cell adhesion	What the earlier library explored: FAK-paxillin and the movement of repair cells	Question to carry into the paper: Was a cellular pathway measured, or a functional outcome?
Reading theme: Gut models	What the earlier library explored: Barrier function and inflammatory injury	Question to carry into the paper: Which model and route were tested?
Reading theme: Thymosin beta-4	What the earlier library explored: Actin, cardiac and repair research	Question to carry into the paper: Was the full-length molecule or the short TB-500 fragment tested?

The growth hormone axis

The older library included CJC-1295 exposure and pulsatility work, ipamorelin characterisation and the historical paediatric GHRH literature. These records help distinguish a measured hormone response from a demonstrated effect on health or function.

Research theme	Why it matters	Interpretation limit
Research theme: CJC-1295 pharmacokinetics	Why it matters: The DAC design changes exposure	Interpretation limit: Formulation identity comes before a comparison of duration.
Research theme: Pulsatility	Why it matters: Drug exposure and hormone rhythm are different	Interpretation limit: Long exposure does not automatically establish the loss of pulses.
Research theme: Ipamorelin selectivity	Why it matters: Releasing pathways can differ in off-target signals	Interpretation limit: Selectivity under experimental conditions is not a complete safety record.
Research theme: Sermorelin and GHRH history	Why it matters: Defined clinical populations help explain a benchmark	Interpretation limit: A historical indication does not establish broad anti-ageing benefit.

Longevity and cellular senescence

The Khavinson-associated pineal-peptide literature raises questions about telomeres, circadian rhythms and ageing. Synthetic epithalon and pineal preparations must be separated. A telomerase observation is not a demonstrated extension of human life.

FOXO4-DRI concerns senescent cells, which have stopped dividing. The engineered senolytic idea raises questions about selective cell removal and toxicity. A preclinical result cannot establish a general rejuvenation treatment.

Copper-binding and dermal research

GHK-Cu work concerns gene expression, tissue remodelling, antioxidants and repair. Gene-expression changes are experimental measurements; they do not measure biological years reversed. Topical cosmetic outcomes and injectable-drug research remain separate.

Cognition, immunity and the newer frontiers

The retained reading trail also includes discussions of neurological studies, antimicrobial work, immune modulation and the development landscape. Results in a neurological disease cannot establish cognitive enhancement in healthy people.

Mitochondrial signals

MOTS-c and humanin are associated with mitochondrial biology. Their models, delivery and outcomes need separate reading; no current trial phase is inferred from a theme.

Constrained shapes

Cyclic and stapled peptides use structure as a design tool. Stability, cell entry and clinical usefulness remain distinct measurements.

Targeted delivery

Peptide-drug conjugates aim to carry a payload to a target. Success requires evidence of delivery, selectivity and an acceptable balance of benefit and harm.

Vaccines and scaffolds

Immune presentation and self-assembling materials are different applications of peptide design. Neither supports a general claim about the safety of research compounds.

Four recurring reasons to be cautious

Model translation: a rodent or cell result may not hold in people.
Small samples: an effect can be poorly estimated, and uncommon harms can be missed.
Publication bias: visible positive findings may not represent all work attempted.
Replication: related papers from one group are different from independent confirmation.

How to use the trail

Choose the mechanism class, open a source and identify what it actually tested. Follow its references and later work, then return to the relevant compound profile. Record disagreements rather than resolving them by counting enthusiastic summaries.

The source trail is a starting point for reading. A link alone does not establish that a paper supports a broad clinical claim. Corrections belong at the editorial desk.